KR20090053752A - 중합성 생계면활성제 - Google Patents

중합성 생계면활성제 Download PDF

Info

Publication number
KR20090053752A
KR20090053752A KR1020087032154A KR20087032154A KR20090053752A KR 20090053752 A KR20090053752 A KR 20090053752A KR 1020087032154 A KR1020087032154 A KR 1020087032154A KR 20087032154 A KR20087032154 A KR 20087032154A KR 20090053752 A KR20090053752 A KR 20090053752A
Authority
KR
South Korea
Prior art keywords
seq
polymerizable
acylated biosurfactant
acylated
biosurfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087032154A
Other languages
English (en)
Korean (ko)
Inventor
도널드 오웬
릴리 판
Original Assignee
데라퓨틱 펩타이즈, 인코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데라퓨틱 펩타이즈, 인코포레이션 filed Critical 데라퓨틱 펩타이즈, 인코포레이션
Publication of KR20090053752A publication Critical patent/KR20090053752A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020087032154A 2006-06-01 2007-05-31 중합성 생계면활성제 Ceased KR20090053752A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80982506P 2006-06-01 2006-06-01
US60/809,825 2006-06-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020147015813A Division KR101552453B1 (ko) 2006-06-01 2007-05-31 중합성 생계면활성제

Publications (1)

Publication Number Publication Date
KR20090053752A true KR20090053752A (ko) 2009-05-27

Family

ID=38802034

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020087032154A Ceased KR20090053752A (ko) 2006-06-01 2007-05-31 중합성 생계면활성제
KR1020147015813A Expired - Fee Related KR101552453B1 (ko) 2006-06-01 2007-05-31 중합성 생계면활성제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020147015813A Expired - Fee Related KR101552453B1 (ko) 2006-06-01 2007-05-31 중합성 생계면활성제

Country Status (7)

Country Link
US (1) US8586541B2 (https=)
EP (1) EP2037942B1 (https=)
JP (1) JP5697869B2 (https=)
KR (2) KR20090053752A (https=)
CN (2) CN105288581A (https=)
CA (1) CA2654008C (https=)
WO (1) WO2007143006A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261421B2 (en) 2016-06-27 2022-03-01 Cosmax Co., Ltd. Sporichthyaceae microorganism and use thereof

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008045766A2 (en) * 2006-10-10 2008-04-17 True Look Skin Care Inc. Method for treating skin
SG10201607909WA (en) * 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
CN107028792A (zh) * 2008-05-29 2017-08-11 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
US8318678B2 (en) 2008-05-30 2012-11-27 Jan Marini Skin Research Cosmetic compositions
CN102203117A (zh) * 2008-11-04 2011-09-28 安科治疗公司 Apj受体化合物
FR2944016B1 (fr) * 2009-04-02 2012-03-09 Isp Investments Inc Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
DK3777876T3 (da) * 2011-10-28 2023-10-30 Neostrata Company Inc N-acyldipeptid-derivater og anvendelser deraf
US20140349920A1 (en) * 2012-01-03 2014-11-27 Ruey J. Yu N-acylpeptide derivatives and their uses
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
CN105189531B (zh) 2013-03-13 2020-02-21 安特易斯有限公司 用于皮肤复新的肽及其使用方法
EP2859883B1 (en) 2013-10-13 2019-05-15 Symrise AG Active mixtures comprising acylated oligopeptides and troxerutin
WO2016194760A1 (ja) * 2015-05-29 2016-12-08 ロート製薬株式会社 美容方法およびそれに用いる皮膚外用剤、並びに遊走付与剤、皮膚状態を向上させる美容方法に用いられる成分のスクリーニング方法
DE102015217504A1 (de) 2015-09-14 2017-03-16 Henkel Ag & Co. Kgaa Peeling mit Biotensiden
CN107028987A (zh) * 2017-04-11 2017-08-11 成都吉氧屋科技有限公司 一种微生物黏附率调节剂及其应用
CN111759748B (zh) * 2020-08-14 2023-04-11 广州市乾相生物科技有限公司 一种抗衰老肽类组合物及其应用
KR102219317B1 (ko) * 2020-10-06 2021-02-24 엘앤피코스메틱 (주) 천연 보습인자를 이용하여 형성된 미셀 복합체를 포함하는 화장료 조성물의 제조방법 및 이로부터 제조된 화장료 조성물
CN114957384B (zh) * 2022-04-14 2023-11-14 湖北泓肽生物科技有限公司 一种二肽-4的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
KR100279540B1 (ko) * 1992-07-29 2001-02-01 슈테펜 엘.네스비트 펩티드 폐 계면활성제 및 치료용 혼합물
WO1998015179A1 (en) * 1996-10-08 1998-04-16 University Of Washington Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments
GB9809084D0 (en) * 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6875744B2 (en) * 2001-03-28 2005-04-05 Helix Biomedix, Inc. Short bioactive peptides
KR100891157B1 (ko) * 2001-03-28 2009-04-07 헬릭스 바이오메딕스, 인코포레이티드 짧은 생물활성 펩티드 및 그것들의 사용 방법
FR2826266B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
JP2004323401A (ja) * 2003-04-23 2004-11-18 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
US7863417B2 (en) * 2003-05-08 2011-01-04 Dsm Ip Assets B.V. Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure
JP4256389B2 (ja) 2003-11-17 2009-04-22 セダーマ テトラペプチドとトリペプチドの混合物を含む組成物
FR2865639B1 (fr) 2004-01-29 2007-10-19 Oreal Procede de preparation d'une composition de traitement cosmetique a partir de fluide sous pression, et d'acides amines, de peptides et de proteines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261421B2 (en) 2016-06-27 2022-03-01 Cosmax Co., Ltd. Sporichthyaceae microorganism and use thereof
US11634685B2 (en) 2016-06-27 2023-04-25 Cosmax Co., Ltd. Sporichthyaceae microorganism and use thereof

Also Published As

Publication number Publication date
JP5697869B2 (ja) 2015-04-08
CN105288581A (zh) 2016-02-03
US8586541B2 (en) 2013-11-19
CA2654008A1 (en) 2007-12-13
KR101552453B1 (ko) 2015-09-11
WO2007143006A3 (en) 2008-02-28
CA2654008C (en) 2015-11-24
WO2007143006A2 (en) 2007-12-13
EP2037942B1 (en) 2014-09-03
KR20140097340A (ko) 2014-08-06
EP2037942A2 (en) 2009-03-25
US20100144643A1 (en) 2010-06-10
CN101600441A (zh) 2009-12-09
EP2037942A4 (en) 2012-04-25
JP2009538917A (ja) 2009-11-12

Similar Documents

Publication Publication Date Title
KR101552453B1 (ko) 중합성 생계면활성제
US11001607B2 (en) Peptide, composition comprising said peptide and uses thereof, in particular cosmetic uses
JP6230566B2 (ja) 皮膚化粧用組成物におけるオリゴマーバイオサーファクタント
AU2010213094B2 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
ES2397890B1 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
US7977308B2 (en) Lys-Thr dipeptides and their use
KR101264441B1 (ko) 올리고펩티드 및 그의 화장용 용도
KR20130108828A (ko) 올리고펩타이드를 포함하는 피부 미백용 조성물
ES2906178T3 (es) Aminoácido o péptido N-lipoico, derivados y sus usos
EP4188319A1 (en) Cosmetic or dermatological peptide-based treatment of the skin and its integuments
KR20220079586A (ko) 피부 및 피부 부속물의 펩티드 기반 화장 또는 피부과학적 처치

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081231

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120531

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130827

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140210

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130827

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20140513

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20140210

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20160120

Appeal identifier: 2014101002842

Request date: 20140513

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20140611

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20140611

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20140513

Patent event code: PB09011R01I

B601 Maintenance of original decision after re-examination before a trial
E801 Decision on dismissal of amendment
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20140730

PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20140730

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20140611

J801 Dismissal of trial

Free format text: TRIAL NUMBER: 2014101002842; REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20140513

Effective date: 20160120

PJ0801 Rejection of trial

Patent event date: 20160120

Patent event code: PJ08011S01D

Comment text: Decision on Dismissal of Request for Trial (Dismissal of Decision)

Decision date: 20160120

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2014101002842

Request date: 20140513